Eric P Krenning

Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.

Raffaella Barone, Françoise Borson-Chazot, François Jamar, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.

Marion de Jong, R. Valkema, E. Krenning, 2010, Endocrine-related cancer.

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship.

Raffaella Barone, Françoise Borson-Chazot, François Jamar, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.

Marion de Jong, Raffaella Barone, L. Kvols, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

Giovanni Paganelli, Lisa Bodei, Stanislas Pauwels, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors.

Raffaella Barone, Stanislas Pauwels, L. Kvols, 2006, Seminars in nuclear medicine.

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival.

E. Krenning, C. V. van Eijck, D. Kwekkeboom, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors.

E. Krenning, D. Kwekkeboom, W. D. de Herder, 2011, Endocrinology and metabolism clinics of North America.

Somatostatin receptor imaging.

E. Krenning, D. Kwekkeboom, Eric P Krenning, 2002, Seminars in nuclear medicine.

Candidates for peptide receptor radiotherapy today and in the future.

E. Krenning, J. Reubi, Jean Claude Reubi, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.

Magda Bijster, E. Krenning, M. de Jong, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.